113 related articles for article (PubMed ID: 20201736)
1. Computational methods to predict the reactivity of nanoparticles through structure-property relationships.
Poater A; Gallegos Saliner A; Solà M; Cavallo L; Worth AP
Expert Opin Drug Deliv; 2010 Mar; 7(3):295-305. PubMed ID: 20201736
[TBL] [Abstract][Full Text] [Related]
2. Toward in silico approaches for investigating the activity of nanoparticles in therapeutic development.
Saliner AG; Poater A; Worth AP
IDrugs; 2008 Oct; 11(10):728-32. PubMed ID: 18828072
[TBL] [Abstract][Full Text] [Related]
3. Modeling the structure-property relationships of nanoneedles: A journey toward nanomedicine.
Poater A; Saliner AG; Carbó-Dorca R; Poater J; Solà M; Cavallo L; Worth AP
J Comput Chem; 2009 Jan; 30(2):275-84. PubMed ID: 18615420
[TBL] [Abstract][Full Text] [Related]
4. Integrin targeted drug and gene delivery.
Wang Z; Chui WK; Ho PC
Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940
[TBL] [Abstract][Full Text] [Related]
5. Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles.
Peltonen L; Valo H; Kolakovic R; Laaksonen T; Hirvonen J
Expert Opin Drug Deliv; 2010 Jun; 7(6):705-19. PubMed ID: 20345326
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Quantum mechanics in structure-based drug design.
Peters MB; Raha K; Merz KM
Curr Opin Drug Discov Devel; 2006 May; 9(3):370-9. PubMed ID: 16729734
[TBL] [Abstract][Full Text] [Related]
8. Micro- and nanocarrier-mediated lung targeting.
Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
[TBL] [Abstract][Full Text] [Related]
9. Cationic nanoparticles for cancer therapy.
Bilensoy E
Expert Opin Drug Deliv; 2010 Jul; 7(7):795-809. PubMed ID: 20446858
[TBL] [Abstract][Full Text] [Related]
10. In silico-aided prediction of biological properties of chemicals: oestrogen receptor-mediated effects.
Roncaglioni A; Benfenati E
Chem Soc Rev; 2008 Mar; 37(3):441-50. PubMed ID: 18224255
[TBL] [Abstract][Full Text] [Related]
11. Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery.
Delehanty JB; Boeneman K; Bradburne CE; Robertson K; Medintz IL
Expert Opin Drug Deliv; 2009 Oct; 6(10):1091-112. PubMed ID: 19691443
[TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional atomic force microscopy for drug discovery: a versatile tool for defining targets, designing therapeutics and monitoring their efficacy.
Lal R; Arnsdorf MF
Life Sci; 2010 Apr; 86(15-16):545-62. PubMed ID: 20359578
[TBL] [Abstract][Full Text] [Related]
14. Computational enzymology: insight into biological catalysts from modelling.
van der Kamp MW; Mulholland AJ
Nat Prod Rep; 2008 Dec; 25(6):1001-14. PubMed ID: 19030602
[TBL] [Abstract][Full Text] [Related]
15. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage.
Pieper IA; Bertau M
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):747-60. PubMed ID: 20367108
[TBL] [Abstract][Full Text] [Related]
16. Application of nanotechnology in biomedicine.
Navalakhe RM; Nandedkar TD
Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
[TBL] [Abstract][Full Text] [Related]
17. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
Cheon J; Lee JH
Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
[TBL] [Abstract][Full Text] [Related]
18. Medicated chewing gum--a potential drug delivery system.
Chaudhary SA; Shahiwala AF
Expert Opin Drug Deliv; 2010 Jul; 7(7):871-85. PubMed ID: 20560779
[TBL] [Abstract][Full Text] [Related]
19. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery.
Leary SP; Liu CY; Apuzzo ML
Neurosurgery; 2006 Jun; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880
[TBL] [Abstract][Full Text] [Related]
20. Modelling enzyme reaction mechanisms, specificity and catalysis.
Mulholland AJ
Drug Discov Today; 2005 Oct; 10(20):1393-402. PubMed ID: 16253878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
